BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 3695984)

  • 1. Production of bacteriocin-like substances by human oral streptococci.
    Fabio U; Bondi M; Manicardi G; Messi P; Neglia R
    Microbiologica; 1987 Oct; 10(4):363-70. PubMed ID: 3695984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus mutans: classification in bacteriocin-types.
    Bondi M; Neglia RG; Messi P; Manicardi G; Fabio U
    Microbiologica; 1991 Jul; 14(3):223-8. PubMed ID: 1921743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotypes and extracellular bacteriocin (mutacin) production among strains of Streptococcus mutans isolated from the human oral cavity].
    Nishino M; Imanishi H; Okita Y
    Shoni Shikagaku Zasshi; 1986; 24(4):765-76. PubMed ID: 3505072
    [No Abstract]   [Full Text] [Related]  

  • 4. ["In vitro" study of the bacteriocinogenic capacity of Streptococcus mutans].
    Baca García P; Liébana Ureña J; Baca García A
    Av Odontoestomatol; 1991 Jun; 7(6):471-4. PubMed ID: 1892499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii.
    Wang BY; Kuramitsu HK
    Appl Environ Microbiol; 2005 Jan; 71(1):354-62. PubMed ID: 15640209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterisation of the inhibitory substances produced by Streptococcus oralis and related species.
    Willcox MD; Drucker DB
    Microbios; 1988; 55(224-225):135-45. PubMed ID: 3216798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis of Mutacin B-Ny266, a Lantibiotic Active against Caries Pathogens.
    Dufour D; Barbour A; Chan Y; Cheng M; Rahman T; Thorburn M; Stewart C; Finer Y; Gong SG; Lévesque CM
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fluoride on the acid production of Streptococcus mutans and other oral streptococci.
    Okuda K; Frostell G
    Swed Dent J; 1982; 6(1):29-36. PubMed ID: 6951312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Streptococcus sobrinus 6715 (g) in plaques by Streptococcus mutans 32K (c).
    Ikeda T; Kurita T; Hirasawa M
    J Oral Pathol; 1988 Nov; 17(9-10):471-4. PubMed ID: 3150434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a Streptococcus mutans strain producing a novel bacteriocin.
    Hillman JD; Johnson KP; Yaphe BI
    Infect Immun; 1984 Apr; 44(1):141-4. PubMed ID: 6706403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriocins as factors in the in vitro interaction between oral streptococci in plaque.
    Weerkamp A; Bongaerts-Larik L; Vogels GD
    Infect Immun; 1977 Jun; 16(3):773-80. PubMed ID: 892898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutacin production by Streptococcus mutans may promote transmission of bacteria from mother to child.
    Grönroos L; Saarela M; Mättö J; Tanner-Salo U; Vuorela A; Alaluusua S
    Infect Immun; 1998 Jun; 66(6):2595-600. PubMed ID: 9596721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus oligofermentans inhibits Streptococcus mutans through conversion of lactic acid into inhibitory H2O2: a possible counteroffensive strategy for interspecies competition.
    Tong H; Chen W; Merritt J; Qi F; Shi W; Dong X
    Mol Microbiol; 2007 Feb; 63(3):872-80. PubMed ID: 17302806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic substances produced by streptococci from human dental plaque and their significance in plaque ecology.
    Weerkamp A; Vogels GD; Skotnicki M
    Caries Res; 1977; 11(5):245-56. PubMed ID: 267511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lysis of oral streptococci by an extracellular enzyme from the bacterium Streptococcus mutans].
    Nosaki Y
    Kanagawa Shigaku; 1989 Sep; 24(2):384-92. PubMed ID: 2489656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of cell-free bacteriocin (mutacin) produced by Streptococcus mutans and its effect on microflora of dental plaque].
    Imanishi H
    Osaka Daigaku Shigaku Zasshi; 1982 Jun; 27(1):89-106. PubMed ID: 6957581
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and properties of bacteriocins (mutacins) from Streptococcus mutans.
    Hamada S; Ooshima T
    Arch Oral Biol; 1975 Oct; 20(10):641-8. PubMed ID: 1059386
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and biochemical characterization of mutacin VSM43 isolated from human oral Streptococcus mutans VSM43.
    Ahmad S; Rasool SA
    Pak J Pharm Sci; 2003 Jul; 16(2):43-50. PubMed ID: 16414575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci.
    James SM; Tagg JR
    N Z Dent J; 1991 Jul; 87(389):80-3. PubMed ID: 1956623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriocins of Streptococcus mutans: mutacins].
    Baca Garcia P; Liebana Ureña J
    Rev Eur Odontoestomatol; 1990; 2(2):127-30. PubMed ID: 2222663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.